American Journal of Clinical Dermatology

Article	Citations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	182
Economic Burden of Chronic Hand Eczema: A Review	152
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	145
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	101
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	90
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	87
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	83
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	81
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review	79
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	77
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	75
The Burden of Pediatric Psoriasis: A Systematic Review	73
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	58
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	57
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	56
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	55
Pathophysiology of Generalized Pustular Psoriasis	54
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data	54
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	53
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	53
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	51
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	51
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	49
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	48
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	48

Skin Cancer in People of Color: A Systematic Review	45
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature	44
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials	44
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	43
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	42
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	40
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	40
A Practice Approach to Acne Fulminans in Adolescents	40
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	39
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review	38
Patient and Public Involvement in Dermatology Research: A Review	37
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	37
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	37
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	37
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	36
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	36
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	35
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options	34
Oral Lichen Planus: An Update on Diagnosis and Management	34
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	34
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	33
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	33
Individualized Neoantigen-Directed Melanoma Therapy	33
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	32
Frontal Fibrosing Alopecia: An Update	31
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	30
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	29
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	29
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	29
Targeting Inflammation in Acne: Current Treatments and Future Prospects	27
Advancing Precision Medicine in Inflammatory Skin Disease	27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	26
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	26
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	25
Acknowledgement to Referees	25
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	25
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	25
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	24
Management of Acne in Pregnancy	24
Identifying and Treating Ocular Manifestations in Psoriasis	23
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results	23
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	23
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	23
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	22
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	22
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review	22
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	22
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians	22
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	21
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey	21

Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management	21
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	21
Approach to the Atypical Wound	21
Safety of Hydroxychloroquine: What a Dermatologist Should Know	20
Is There a Place for Biologics in Acne?	20
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	20
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	19
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	19
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	18
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	18
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	18
An Update on New and Existing Treatments for the Management of Melasma	18
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	18
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	18
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	17
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	17
Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study	17
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	17
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	17
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents	17
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	16
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	16
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	16
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	16
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study	16
Psychosocial Effects of Vitiligo: A Systematic Literature Review	16
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	15
Treatment of Hyperhidrosis: An Update	15
Atopic Dermatitis Across Shades of Skin	15
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts	15
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	15
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	14
Lichen Planus: What is New in Diagnosis and Treatment?	14
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey	14
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	14
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	14
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	14
New Practical Aspects of Sweet Syndrome	13
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	13
Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients	13
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	13
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	13
Meat Allergy: A Ticking Time Bomb	12
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases	12
Dapsone Use in Dermatology	12
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma	12
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”	12
Diagnosis of Generalized Pustular Psoriasis	11
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	11
Alopecia in Children with Cancer: A Review from Pathophysiology to Management	11
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	11
Correction to: Adherence to Hidradenitis Suppurativa Treatment	10
Eyebrow and Eyelash Alopecia: A Clinical Review	10
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies	10
Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies	10
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	10
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	10
Efinaconazole in Onychomycosis	10
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast	10
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	10
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview	10
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	9
Adherence to Hidradenitis Suppurativa Treatment	9
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	9
Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program	9
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review	9
What’s New in Therapy for Male Androgenetic Alopecia?	9
Alopecia Areata: Current Treatments and New Directions	9
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	8
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	8
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS)	8
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity	8
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	8
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	8
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	8
Deucravacitinib for the Treatment of Psoriatic Disease	8
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	8
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	7
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System	7
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	7

Psoriasis: Considerations for the Management of Women of Childbearing Potential	7
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	7
Pruritus in Pregnancy	7
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	7
Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	6
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	6
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	6
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	6
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	6
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	6
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	6
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?	6
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024	6
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	6
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	6
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial	6
Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials	6
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study	6